ArticleClinical ophthalmology (Auckland, N.Z.)2016
Phacoemulsification without preoperative mydriasis in patients with age-related cataract associated with type 2 diabetes.
Article in Clinical ophthalmology (Auckland, N.Z.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 15 citations in OpenAlex.
- Safety and efficacy of a standardized intracameral combination of mydriatics and anesthetic for cataract surgery in type-2 diabetic patients.BMC ophthalmology · 2020Trial
- Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and Anaesthetic.Life (Basel, Switzerland) · 2025Article
- Mydriasis mediated by local anesthetics: an unexpected adverse event or new therapeutic indication?Therapeutic advances in drug safety · 2025Review
- Intraocular lens selection in diabetic patients: How to increase the odds for success.World journal of diabetes · 2024Review
- Effectiveness of a Standardized Combination of Intracameral Mydriatics and Anaesthetic on Mydriasis during Cataract Surgery with Coexisting Diseases.Life (Basel, Switzerland) · 2023Article
- A novel Y-shaper and chopper for small pupil management in cataract surgery: The initial experience.Indian journal of ophthalmology · 2023Article
- Use of Cryopreserved Amniotic Membrane During Pterygium Excision: Health Economic Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2023Article
- Cataract Surgery Considerations for Diabetic Patients.Current diabetes reports · 2021Review
- Diabetes and Phacoemulsification Cataract Surgery: Difficulties, Risks and Potential Complications.Journal of clinical medicine · 2019Review
- Risk factors for intraoperative floppy iris syndrome in female cataract patients: The roles of ARB medication and diabetes mellitus.Advances in ophthalmology practice and researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo study the effect of intracameral injection of preservative-free lignocaine to induce pupil dilatation, without using any preoperative dilating eyedrops or intraoperative mydriatics in patients with age-related cataract associated with type 2 diabetes mellitus.
designThis was a prospective, observational, and interventional case series conducted at a tertiary eyecare center in rural India. MATERIALS AND
methodsA total of 32 patients underwent phacoemulsification under topical anesthesia for visually significant cataract. Preoperative pupillary diameter was measured 3 days prior to surgical procedure under mydriatics (tropicamide 0.8%, phenylephrine hydrochloride 5%). Intraoperative pupillary dilatation was achieved by 1% intracameral lignocaine solution alone. Effective phacoemulsification time (EPT), total surgical time, and final pupillary diameter were recorded at the conclusion of surgery.
resultsThe average duration of diabetes was 11.2 (range 5-25) years. There was no difference in dilatation by preoperative pupil-dilating drops (5.2±0.5 mm, range 3-8.3 mm) and intracameral 1% lignocaine during the surgical procedure (
conclusionIntracameral lignocaine 1% provides sufficient mydriasis for the safe phacoemulsification of cataract in patients with type 2 diabetes of variable duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.